Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. audio, 8-K earnings release, 8-K call announcement, 10-K stay in one workspace.
DNLI
$19.28
-3.16%
DNLI
· Denali Therapeutics Inc.
$19.28
-0.63 (-3.16%)
At close · Oct 6
Return incl. dividend (before tax)
Market Cap
$3.25B
Shares
159.85M
Volume · Oct 6
3.67M
Avg daily vol (3M)
1.61M
All webcasts
Earnings call · FY2025 Q4
Denali Therapeutics Inc. (DNLI) Q4 2025 Earnings Call
Research coverage
4 live sources
Switch sources without leaving this page or losing your listening position.
Net income · derived Q4
-$128.55M
Research materials
Open the source you need; every reader stays inside this workspace.
Listen to the call
Audio replay
Play the complete captured earnings call.
1:07:17
Audio
Audio replay
A speaker-labelled transcript is not available for this event yet.
SEC filing · Item 2.02
8-K earnings release
Filed Feb 26, 2026 · complete as-filed document
SEC periodic report
10-K report
Filed Feb 26, 2026 · complete as-filed document
SEC call announcement
8-K call announcement
Filed Mar 25, 2026 · complete as-filed document